{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:07:17Z","timestamp":1790298437032,"version":"4.1.0"},"reference-count":17,"publisher":"SAGE Publications","issue":"14","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Mult Scler"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Diroximel fumarate (DRF) is approved for adults with relapsing\u2013remitting multiple sclerosis (RRMS) in Europe and for relapsing forms of MS in the United States. DRF and dimethyl fumarate (DMF) yield bioequivalent exposure of the active metabolite monomethyl fumarate. Prior studies indicated fewer gastrointestinal (GI)-related adverse events (AEs) with DRF compared with DMF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To report final outcomes from EVOLVE-MS-1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>EVOLVE-MS-1 was an open-label, 96-week, phase 3 study assessing DRF safety, tolerability, and efficacy in patients with RRMS. The primary endpoint was safety and tolerability; efficacy endpoints were exploratory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Overall, 75.7% (800\/1057) of patients completed the study; median exposure was 1.8 (range: 0.0\u20132.0) years. AEs occurred in 938 (88.7%) patients, mostly of mild (28.9%) or moderate (50.3%) severity. DRF was discontinued due to AEs in 85 (8.0%) patients, with &lt; 2% discontinuing due to GI or flushing\/flushing-related AEs. At Week 96, mean number of gadolinium-enhancing lesions was significantly reduced from baseline (72.7%; p &lt; 0.0001); adjusted annualized relapse rate was 0.13 (95% confidence interval: 0.11\u20130.15).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>DRF was generally well tolerated over 2 years, with few discontinuations due to AEs; radiological measures indicated decreased disease activity from baseline. These outcomes support DRF as a treatment option in patients with RRMS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13524585231205708","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T06:36:11Z","timestamp":1698734171000},"page":"1795-1807","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":25,"title":["Diroximel fumarate in patients with relapsing\u2013remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study"],"prefix":"10.1177","volume":"29","author":[{"given":"Barry A","family":"Singer","sequence":"first","affiliation":[{"name":"The MS Center for Innovations in Care, Missouri Baptist Medical Center, St Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4266-0106","authenticated-orcid":false,"given":"Douglas L","family":"Arnold","sequence":"additional","affiliation":[{"name":"Montreal Neurological Institute, McGill University, Montreal, QC, Canada"},{"name":"NeuroRx Research Inc., Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4516-3458","authenticated-orcid":false,"given":"Jelena","family":"Drulovic","sequence":"additional","affiliation":[{"name":"Clinic of Neurology, University of Belgrade, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S","family":"Freedman","sequence":"additional","affiliation":[{"name":"University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ruhr University Bochum, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gudesblatt","sequence":"additional","affiliation":[{"name":"NYU Langone South Shore Neurologic Associates, Patchogue, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0016-9896","authenticated-orcid":false,"given":"Elzbieta","family":"Jasinska","sequence":"additional","affiliation":[{"name":"Collegium Medicum UJK, and Clinical Center, RESMEDICA, Kielce, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C","family":"LaGanke","sequence":"additional","affiliation":[{"name":"North Central Neurology Associates, Cullman, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0520-4283","authenticated-orcid":false,"given":"Robert T","family":"Naismith","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine, St Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Negroski","sequence":"additional","affiliation":[{"name":"MS Center of Sarasota, Sarasota, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5519-6088","authenticated-orcid":false,"given":"Jiwon","family":"Oh","sequence":"additional","affiliation":[{"name":"Division of Neurology, St. Michael\u2019s Hospital, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Hernandez Perez","sequence":"additional","affiliation":[{"name":"Hospital Universitario Nuestra Se\u00f1ora de Candelaria, Santa Cruz de Tenerife, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Selmaj","sequence":"additional","affiliation":[{"name":"Center of Neurology, Lodz, Poland"},{"name":"Department of Neurology, University of Warmia and Mazury, Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Then Bergh","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Wundes","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Washington Medical Center, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8799-8202","authenticated-orcid":false,"given":"Tjalf","family":"Ziemssen","sequence":"additional","affiliation":[{"name":"Center of Clinical Neuroscience, Carl Gustav Carus University Hospital, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9018-4263","authenticated-orcid":false,"given":"Wanda","family":"Castro-Borrero","sequence":"additional","affiliation":[{"name":"Biogen, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailu","family":"Chen","sequence":"additional","affiliation":[{"name":"Biogen, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Levin","sequence":"additional","affiliation":[{"name":"Biogen, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Scaramozza","sequence":"additional","affiliation":[{"name":"Biogen, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai L","family":"Shankar","sequence":"additional","affiliation":[{"name":"Biogen, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[{"name":"Biogen, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibyl","family":"Wray","sequence":"additional","affiliation":[{"name":"Hope Neurology MS Center, Knoxville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"bibr1-13524585231205708","volume-title":"Summary of product characteristics","author":"Vumerity","year":"2022"},{"key":"bibr2-13524585231205708","volume-title":"Prescribing information","author":"Vumerity","year":"2023"},{"key":"bibr3-13524585231205708","volume-title":"Prescribing information","author":"Tecfidera","year":"2023"},{"key":"bibr4-13524585231205708","doi-asserted-by":"crossref","first-page":"P1403","DOI":"10.1212\/WNL.90.15_supplement.P1.403","volume":"90","author":"Wehr A","year":"2018","journal-title":"Neurology"},{"key":"bibr5-13524585231205708","volume":"5","author":"Berger T","year":"2019","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"bibr6-13524585231205708","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1206328"},{"key":"bibr7-13524585231205708","doi-asserted-by":"publisher","DOI":"10.1177\/1756286420915005"},{"key":"bibr8-13524585231205708","doi-asserted-by":"publisher","DOI":"10.1177\/13524585211037909"},{"key":"bibr9-13524585231205708","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114287"},{"key":"bibr10-13524585231205708","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.10.011"},{"key":"bibr11-13524585231205708","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-01085-3"},{"key":"bibr12-13524585231205708","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00700-0"},{"key":"bibr13-13524585231205708","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519881761"},{"key":"bibr14-13524585231205708","doi-asserted-by":"publisher","DOI":"10.7224\/1537-2073.2014-069"},{"key":"bibr15-13524585231205708","doi-asserted-by":"publisher","DOI":"10.1177\/1756286421993999"},{"key":"bibr16-13524585231205708","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.809273"},{"key":"bibr17-13524585231205708","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jnnp-2016-314597.33","volume":"87","author":"De Stefano N","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Multiple Sclerosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13524585231205708","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13524585231205708","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13524585231205708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:13:26Z","timestamp":1777695206000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13524585231205708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":17,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1177\/13524585231205708"],"URL":"https:\/\/doi.org\/10.1177\/13524585231205708","relation":{},"ISSN":["1352-4585","1477-0970"],"issn-type":[{"value":"1352-4585","type":"print"},{"value":"1477-0970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]}}}